Sodium-Glucose Cotransporter-2 Inhibitor in Diabetic and Nondiabetic Renal Transplant Recipients
SGLT2i have been used in KTRs since their authorization in France. They were discontinued more frequently in patients with impaired graft function; however, the expected side effects were infrequent and not life-threatening. The short-term antiproteinuric and antihypertensive effects are promising.
Authors
- Manon Dekeyser (ORCID: https://orcid.org/0000-0002-1829-3767)
- Peggy Perrin (ORCID: https://orcid.org/0000-0001-7343-5943)
- Bénédicte Sautenet (ORCID: https://orcid.org/0000-0001-8430-4543)
- Dominique Bertrand
- Cyril Garrouste (ORCID: https://orcid.org/0000-0001-5166-5617)
- Dany Anglicheau (ORCID: https://orcid.org/0000-0001-5793-6174)
- Léonard Golbin (ORCID: https://orcid.org/0000-0001-5987-7024)
- Charlotte Boud’hors
- Laure Écotière
- Coralie Poulain
- Valérie Châtelet (ORCID: https://orcid.org/0000-0002-3107-9087)
- Fabien Duthé
- Philippe Gatault (ORCID: https://orcid.org/0000-0003-1664-2879)
- Clément Danthu (ORCID: https://orcid.org/0000-0002-0738-4516)
- Pierre-Guillaume Deliège (ORCID: https://orcid.org/0000-0002-5885-2877)
- Yannick Le Meur (ORCID: https://orcid.org/0000-0001-8913-415X)
- Lucie Maigret
- Lucile Baslé
Institutions
- Université de Tours (FR)
- Hôpital Necker-Enfants Malades (FR)
- Inserm (FR)
- Centre Hospitalier Universitaire de Tours (FR)
- Centre Hospitalier Universitaire Amiens-Picardie (FR)
- Clinical Investigation Center Plurithematic Tours (FR)
- Centre Hospitalier Universitaire de Reims (FR)
- Centre Hospitalier Universitaire de Poitiers (FR)
- Centre Hospitalier Universitaire d'Angers (FR)
- Centre Hospitalier Universitaire de Caen Normandie (FR)
- Centre Hospitalier Universitaire de Limoges (FR)
- Metabolism and Renal Physiology (FR)
- Centre Hospitalier Universitaire de Clermont-Ferrand (FR)
- Centre Hospitalier Régional Universitaire de Brest (FR)
- Centre hospitalier universitaire d'Orléans (FR)
- Hôpitaux Universitaires de Strasbourg (FR)
- Centre Hospitalier Universitaire de Rouen (FR)
- Centre Hospitalier Universitaire de Rennes (FR)
- Université de Rouen Normandie (FR)
- Université de Strasbourg (FR)
- Université de Reims Champagne-Ardenne (FR)
- Université de Caen Normandie (FR)
Publication Details
- Journal
- Kidney International Reports
- Published
- 2024-11-28
- DOI
- https://doi.org/10.1016/j.ekir.2024.11.033
- Citations
- 12
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 4.29
Funders
- AstraZeneca
- AstraZeneca France